| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |